# Waters Moat

Status: published. Policy: company-analysis-1.

Waters has a narrow moat centered on integrated instruments, software, consumables and support that encourage continuing customer dependence. Legacy recurring revenue growth supports an existing advantage, although switching costs are inferred rather than quantified. Pricing power is constrained by demonstrated purchasing and regulatory pressure. The BDS acquisition broadens the business, but its incremental moat and financial benefits remain unproven.

## switching_costs

Integrated LC-MS systems using common software, together with instrument maintenance, validation and training, create workflow dependence and incentives to keep buying Waters support and consumables. Services exceeded 35% of Waters sales in 2025; legacy recurring revenue subsequently grew 9% in the second quarter and 13% in the first half of 2026. These results support continuing demand, though they do not measure customer switching costs or renewal rates.

Durability: Existing workflow integration and continuing maintenance and consumable demand support a potentially multiyear advantage. Its duration is not established: competitors can service Waters instruments, and the supplied passages do not quantify replacement difficulty, qualification costs or customer losses.

Risks: Third-party servicing can weaken aftermarket capture. Competitor innovation can displace platforms, while concentrated purchasing and regulated procurement constrain monetization. The much larger BDS business changes the revenue mix and introduces integration demands; its contribution does not establish stronger customer dependence.

Invalidation: The thesis would weaken materially if legacy consumable and service demand persistently declined despite stable instrument usage, customers increasingly substituted third-party support or consumables, or competing platforms displaced Waters workflows without substantial migration friction. Acquisition-driven consolidated growth would not offset that evidence.

Competitors: Revvity, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific Inc.
- [https://www.sec.gov/Archives/edgar/data/1000697/000119312526062604/d778470d10k.htm](https://www.sec.gov/Archives/edgar/data/1000697/000119312526062604/d778470d10k.htm) · 2026-02-23
- [https://www.sec.gov/Archives/edgar/data/1000697/000119312526344691/d170082d10q.htm](https://www.sec.gov/Archives/edgar/data/1000697/000119312526344691/d170082d10q.htm) · 2026-08-11
- [https://www.sec.gov/Archives/edgar/data/1000697/000119312526149657/d71187ddef14a.htm](https://www.sec.gov/Archives/edgar/data/1000697/000119312526149657/d71187ddef14a.htm) · 2026-04-09

[JSON](https://beanvest.com/stock/wat/moat.json)